Blood coagulation in immunothrombosis—At the frontline of intravascular immunity. Issue 6 (December 2016)

• Record Type: Journal Article
• Authors: Gaertner, Florian; Massberg, Steffen
• Is Part Of: Seminars in immunology. Volume 28:Issue 6(2016)
• Page Start: 561
• Page End: 569
• Publication Date: 2016-12
• Subjects: Immunothrombosis -- Coagulation -- Fibrin -- Innate immunity -- Host defense -- Platelets -- Leukocytes; Immunology -- Periodicals; Allergy and Immunology -- Periodicals; Immunity -- Periodicals; Immunologie -- Périodiques; Electronic journals; 616.079
• DOI: 10.1016/j.smim.2016.10.010
• Languages: English
• ISSNs: 1044-5323

Abstract

Highlights: Immunothrombosis is a physiological effector of the innate immune response. Fibrin formation provides a scaffold for intravascular immunity. Immunothrombosis is a multicellular process involving platelets and leukocytes. Aberrant immunothrombosis underlies pathologies associated with thrombosis. Abstract: While hemostasis is the physiological process that prevents blood loss after vessel injury, thrombosis is often portrayed as a pathologic event involving blood coagulation and platelet aggregation eventually leading to vascular occlusion and tissue damage. However, recent work suggests that thrombosis can also be a physiological process, termed immunothrombosis, initiated by the innate immune system providing a first line of defense to locally control infection. Fibrin forms the structural basis of immunothrombotic clots and its assembly involves the concerted action of coagulation factors, platelets and leukocytes. Here, we summarize the cellular and molecular events that initiate fibrin formation during the innate immune response and discuss how aberrant activation of these pathways fosters pathologies associated with thrombosis, including disseminated intravascular coagulation and atherothrombosis.